The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bireociclib plus fulvestrant for advanced HR+/HER2- breast cancer progressing after endocrine therapy: Interim analysis of a phase 3 trial (BRIGHT-2).
 
Jiayu Wang
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Huiping Li
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Huihui Li
No Relationships to Disclose
 
Yuee Teng
No Relationships to Disclose
 
Biyun Wang
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Jingfen Wang
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Zhaofeng Niu
No Relationships to Disclose
 
Hongsheng Li
No Relationships to Disclose
 
Chang Gong
No Relationships to Disclose
 
Li Wang
Employment - Xuanzhu Biopharmaceutical Co., Ltd.
Honoraria - Xuanzhu Biopharmaceutical Co., Ltd.
 
Fei Liu
Employment - Xuanzhu Biopharmaceutical Co., Ltd.
Honoraria - Xuanzhu Biopharmaceutical Co., Ltd.
 
Shuya Wang
Employment - Xuanzhu Biopharmaceutical Co., Ltd.
Honoraria - Xuanzhu Biopharmaceutical Co., Ltd.
 
Yaping Meng
Employment - Xuanzhu Biopharmaceutical Co., Ltd.
Honoraria - Xuanzhu Biopharmaceutical Co., Ltd.
 
Xianghui Duan
Employment - Xuanzhu Biopharmaceutical Co., Ltd.
Honoraria - Xuanzhu Biopharmaceutical Co., Ltd.
 
Binghe Xu
No Relationships to Disclose